✦ LIBER ✦

Safety and efficacy of first-line bevacizumab-based therapy in advanced non-squamous non-small-cell lung cancer (SAiL, MO19390): a phase 4 study

✍ Scribed by Lucio Crinò; Eric Dansin; Pilar Garrido; Frank Griesinger; Janessa Laskin; Nick Pavlakis; Daniel Stroiakovski; Nick Thatcher; Chun-Ming Tsai; Yi-long Wu; Caicun Zhou

Book ID: 117785407
Publisher: The Lancet
Year: 2010
Tongue: English
Weight: 204 KB
Volume: 11
Category: Article
ISSN: 1470-2045
DOI: 10.1016/s1470-2045(10)70151-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

First-Line Bevacizumab-Based Therapy in

First-Line Bevacizumab-Based Therapy in Advanced Non-Squamous Non-Small-Cell Lung Cancer

✍ Alessandra Bearz, Rodolfo Passalacqua, Oscar Alabiso, Saverio Cinieri, Cesare Gr 📂 Article 📅 2012 🏛 Springer International Publishing AG 🌐 English ⚖ 222 KB

MO19390 (SAiL): Bleeding events in a pha

MO19390 (SAiL): Bleeding events in a phase IV study of first-line bevacizumab with chemotherapy in patients with advanced non-squamous NSCLC

✍ Dansin, Eric; Cinieri, Saverio; Garrido, Pilar; Griesinger, Frank; Isla, Dolores 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 222 KB

Randomized phase II study of first-line

Randomized phase II study of first-line carboplatin-paclitaxel with or without bevacizumab in Japanese patients with advanced non-squamous non-small-cell lung cancer

✍ Niho, Seiji; Kunitoh, Hideo; Nokihara, Hiroshi; Horai, Takeshi; Ichinose, Yukito 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 408 KB

PCN8 REAL LIFE OUTCOMES IN 1ST LINE NON-

PCN8 REAL LIFE OUTCOMES IN 1ST LINE NON-SQUAMOUS NON-SMALL CELL LUNG CANCER (NSCLC): A PILOT STUDY IN FRANCE AND GERMANY ANALYSING BEVACIZUMAB-BASED VERSUS NON-BEVACIZUMAB-BASED TREATMENTS

✍ H.G. Bischoff; C. Chouaid; A. Vergnenegre; D.F. Heigener; G. Taylor-Stokes; A. R 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

PCN94 HEALTH-RELATED QUALITY OF LIFE (HR

✍ C. Chouaid; H.G. Bischoff; A. Vergnenegre; D.F. Heigener; G. Taylor-Stokes; A. R 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

First-line erlotinib and bevacizumab in

First-line erlotinib and bevacizumab in patients with locally advanced and/or metastatic non-small-cell lung cancer: a phase II study including molecular imaging

✍ Dingemans, A.- M. C.; de Langen, A. J.; van den Boogaart, V.; Marcus, J. T.; Bac 📂 Article 📅 2011 🏛 Oxford University Press 🌐 English ⚖ 383 KB